These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37343143)

  • 21. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
    Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
    PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction.
    Gui H; She R; Luzum J; Li J; Bryson TD; Pinto Y; Sabbah HN; Williams LK; Lanfear DE
    Circ Genom Precis Med; 2021 Jun; 14(3):e003140. PubMed ID: 33999650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of tPA/PAI-1 complex in patients with heart failure and preserved ejection fraction.
    Winter MP; Kleber ME; Koller L; Sulzgruber P; Scharnagl H; Delgado G; Goliasch G; März W; Niessner A
    Thromb Haemost; 2017 Feb; 117(3):471-478. PubMed ID: 27975104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of Multiple Circulating Biomarkers for 2-Year Death in Acute Heart Failure With Preserved Ejection Fraction.
    Gao Y; Bai X; Lu J; Zhang L; Yan X; Huang X; Dai H; Wang Y; Hou L; Wang S; Tian A; Li J
    Front Cardiovasc Med; 2021; 8():779282. PubMed ID: 34957261
    [No Abstract]   [Full Text] [Related]  

  • 25. Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction.
    Blanco R; Ambrosio G; Belziti C; Lucas L; Arias A; D'Antonio A; Oberti P; Carluccio E; Pizarro R
    Int J Cardiol; 2020 Oct; 317():111-120. PubMed ID: 32380249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction.
    Löfström U; Hage C; Savarese G; Donal E; Daubert JC; Lund LH; Linde C
    ESC Heart Fail; 2019 Aug; 6(4):830-839. PubMed ID: 31207140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mean platelet volume: a prognostic marker in heart failure with preserved ejection fraction.
    Menghoum N; Beauloye C; Lejeune S; Badii MC; Gruson D; van Dievoet MA; Pasquet A; Vancraeynest D; Gerber B; Bertrand L; Horman S; Pouleur AC
    Platelets; 2023 Dec; 34(1):2188965. PubMed ID: 37157842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.
    Pacho C; Domingo M; Núñez R; Lupón J; Núñez J; Barallat J; Moliner P; de Antonio M; Santesmases J; Cediel G; Roura S; Pastor MC; Tor J; Bayes-Genis A
    BMC Geriatr; 2018 May; 18(1):109. PubMed ID: 29743019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial fibrillation and risk of progressive heart failure in patients with preserved ejection fraction heart failure.
    Gierula J; Cole CA; Drozd M; Lowry JE; Straw S; Slater TA; Paton MF; Byrom RJ; Garland E; Halliday G; Winsor S; Lyall GK; Birch K; McGinlay M; Sunley E; Grant PJ; Wessels DH; Ketiar EM; Witte KK; Cubbon RM; Kearney MT
    ESC Heart Fail; 2022 Oct; 9(5):3254-3263. PubMed ID: 35790085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of sST2 in patients with heart failure with reduced, mid-range and preserved ejection fraction.
    Song Y; Li F; Xu Y; Liu Y; Wang Y; Han X; Fan Y; Cao J; Luo J; Sun A; Hu K; Zhou J; Ge J
    Int J Cardiol; 2020 Apr; 304():95-100. PubMed ID: 32019693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Salah K; Stienen S; Pinto YM; Eurlings LW; Metra M; Bayes-Genis A; Verdiani V; Tijssen JGP; Kok WE
    Heart; 2019 Aug; 105(15):1182-1189. PubMed ID: 30962192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G; Vedin O; D'Amario D; Uijl A; Dahlström U; Rosano G; Lam CSP; Lund LH
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic and prognostic value of galectin-3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST-CHF study.
    Trippel TD; Mende M; Düngen HD; Hashemi D; Petutschnigg J; Nolte K; Herrmann-Lingen C; Binder L; Hasenfuss G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2021 Apr; 8(2):829-841. PubMed ID: 33566456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nomogram for predicting the risk of heart failure with preserved ejection fraction.
    Hua L; Zhang R; Chen R; Shao W
    Int J Cardiol; 2024 Jul; 407():131973. PubMed ID: 38508321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population.
    Chia YC; Kieneker LM; van Hassel G; Binnenmars SH; Nolte IM; van Zanden JJ; van der Meer P; Navis G; Voors AA; Bakker SJL; De Borst MH; Eisenga MF
    J Am Heart Assoc; 2021 Jun; 10(11):e018549. PubMed ID: 33998283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.
    Roy C; Lejeune S; Slimani A; de Meester C; Ahn As SA; Rousseau MF; Mihaela A; Ginion A; Ferracin B; Pasquet A; Vancraeynest D; Beauloye C; Vanoverschelde JL; Horman S; Gruson D; Gerber BL; Pouleur AC
    ESC Heart Fail; 2020 Oct; 7(5):2494-2507. PubMed ID: 32578967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
    Zhu W; Wu Y; Zhou Y; Liang W; Xue R; Wu Z; Dong Y; Liu C
    Cardiovasc Drugs Ther; 2020 Dec; 34(6):763-772. PubMed ID: 32583288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
    Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
    Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
    Park J; Zhong X; Babaie Sarijaloo F; Wokhlu A
    Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.